[1]
“The assessment of Cyclophosphamide Chemotherapy Effect Loading-PLGA Nanoparticles Against Ovarian Cancer Cells Line (OVCAR-4 and PEO1)”, Journal of Pharmaceutical Negative Results, vol. 13, no. 1, pp. 39–43, Jan. 2022, Accessed: Jun. 04, 2026. [Online]. Available: https://www.pnrjournal.com/index.php/home/article/view/180